These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mechanisms of action of extracorporeal photochemotherapy. Heshmati F. Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896 [Abstract] [Full Text] [Related]
4. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. McKenna KE, Whittaker S, Rhodes LE, Taylor P, Lloyd J, Ibbotson S, Russell-Jones R, British Photodermatology Group, UK Skin Lymphoma Group. Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088 [Abstract] [Full Text] [Related]
5. [Extracorporeal photochemotherapy: review of its mechanisms of action and clinical applications]. Vanheste S, Vereecken P, Lambermont M, Heenen M, Bron D. Rev Med Brux; 2007 Jan; 28(5):445-51. PubMed ID: 18069519 [Abstract] [Full Text] [Related]
6. Extracorporeal photopheresis: what is it and when should it be used? Scarisbrick J. Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836 [Abstract] [Full Text] [Related]
13. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Scarisbrick JJ, Taylor P, Holtick U, Makar Y, Douglas K, Berlin G, Juvonen E, Marshall S, Photopheresis Expert Group. Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274 [Abstract] [Full Text] [Related]